Single dose, purified biocompatible vegf a mrna administered one week post myocardial infarction in pigs inhibits cardiac fibrosis and leads to chronic reversal of global ventricular dysfunction
Dapagliflozin is associated with lower risk of hospitalization for heart failure, major adverse cardiovascular events and all-cause death compared to DPP-4i in T2D patients: CVD-REAL Nordic
Total events of hospitalization for heart failure in new users of sglt-2 inhibitors vs other glucose lowering drugs - real world data from 3 countries and more than 45,000 patients: the CVD-REA study
A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effects of 4 Weeks Treatment with Subcutaneous Elamipretide on Left Ventricular Function in Subjects with Stable Heart Failure with Preserved Ejection Fraction: Rationale and d
Speaker:
Associate Professor H. Duengen (Berlin, DE)